Journal
PERSONALIZED MEDICINE
Volume 3, Issue 4, Pages 391-397Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/17410541.3.4.391
Keywords
failure-to-warn; liability; medical malpractice; persorialized medicine; pharmacogenomics
Categories
Ask authors/readers for more resources
Legal liability has the potential to be a powerful driver pushing implementation of personalized medicine. Individuals injured by adverse drug effects are increasingly likely to bring lawsuits alleging that they have a polymorphism or biomarker conferring susceptibility to the drug that should have been identified and used to alter their drug treatment. Likely targets of such lawsuits include drug manufacturers, third party payors, physicians and pharmacists, of which,physicians are most at risk of substantial liability.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available